Watchlist Price Alert

X4 Pharmaceuticals Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

3.36

0.07 (2.13%)

At close: May 09, 2025, 3:59 PM

3.45

2.68%

After-hours: May 09, 2025, 04:57 PM EDT

2.13% (1D)

Bid	3.24
Market Cap	19.45M
Revenue (ttm)	31.36M
Net Income (ttm)	14.6M
EPS (ttm)	2.11
PE Ratio (ttm)	1.59
Forward PE	-8.94
Analyst	Buy

Ask	3.46
Volume	145,082
Avg. Volume (20D)	82,280
Open	3.35
Previous Close	3.29
Day's Range	3.21 - 3.40
52-Week Range	3.05 - 34.20
Beta	0.73

About XFOR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XFOR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XFOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

X4 Pharmaceuticals has released their quartely earnings on May 1, 2025:

Revenue of $28.8M exceeds estimates by $21.77M, with Infinity% YoY growth.

EPS of 0.04 exceeds estimates by 3.79, with 115.38% YoY growth.

Next Earnings Release

X4 Pharmaceuticals Inc. is scheduled to release its earnings on Aug 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-12.99%

X4 Pharmaceuticals shares are trading lower. The c... Unlock content with Pro Subscription

1 month ago

-12.09%

X4 Pharmaceuticals shares are trading lower following a Q4 EPS miss.

News

1 week ago · seekingalpha.com

X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call Transcript

1 week ago · benzinga.com

Top 3 Health Care Stocks That May Rocket Higher In April

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

1 month ago · seekingalpha.com

X4 Pharmaceuticals, Inc. (XFOR) Q4 2024 Earnings Call Transcript

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Daniel Ferry - IR, LifeSci Advisors Paula Ragan - CEO Adam Mostafa - CFO Christo...